Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells

Bioorg Med Chem Lett. 2010 May 1;20(9):2994-7. doi: 10.1016/j.bmcl.2010.02.062. Epub 2010 Feb 25.

Abstract

Cucurbitane-type triterpenes, cucurbitacins B and E, were reported to exhibit cytotoxic effects in several cell lines mediated by JAK/STAT3 signaling. However, neither compound inhibited phosphorylation of STAT3 in human leukemia (U937) cells at low concentrations. We therefore synthesized a biotin-linked cucurbitacin E to isolate target proteins based on affinity for the molecule. As a result, cofilin, which regulates the depolymerization of actin, was isolated and suggested to be a target. Cucurbitacins E and I inhibited the phosphorylation of cofilin in a concentration-dependent manner, and their effective concentrations having the same range as the concentrations at which they had cytotoxic effects in U937 cells. In addition, the fibrous-/globular-actin ratio was decreased after treatment with cucurbitacin E in HT1080 cells. These findings suggested that the inhibition of cofilin's phosphorylation increased the severing activity of cofilin, and then the depolymerization of actin was enhanced after treatment with cucurbitacin E at lower concentrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity
  • Cell Line, Tumor
  • Cofilin 1 / antagonists & inhibitors
  • Cofilin 1 / metabolism*
  • Humans
  • Phosphorylation
  • STAT3 Transcription Factor / metabolism
  • Triterpenes / chemistry*
  • Triterpenes / toxicity
  • U937 Cells

Substances

  • Actins
  • Antineoplastic Agents
  • Cofilin 1
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Triterpenes
  • cucurbitacin B
  • cucurbitacin I
  • cucurbitacin E